Search research articles
Contact Us
Filters
Showing results (41-50 of 326) with videos related to
Page
of 33
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 9, 2021
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis
Jesús Rivera-Esteban, Angelo Armandi, Salvador Augustin, et al.
Metabolites
|
April 3, 2021
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism: Clinical and Experimental
|
November 21, 2024
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
BMJ (Clinical Research Ed.)
|
January 19, 2021
Management of non-alcoholic fatty liver disease
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology
|
October 27, 2025
Reply to Yang et al
Nuria Perez-Diaz-Del-Campo, Zobair M Younossi, Elisabetta Bugianesi
Metabolism: Clinical and Experimental
|
September 6, 2016
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists
Stergios A Polyzos, Elisabetta Bugianesi, Jannis Kountouras, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2013
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis
Federico Salomone, Giovanni Li Volti, Chiara Rosso, et al.
Nutrients
|
February 13, 2025
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies
Eleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, et al.
Frontiers in Endocrinology
|
December 3, 2021
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Nature Reviews. Gastroenterology & Hepatology
|
January 4, 2026
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Page
of 33
Search research articles
Search
Showing results (41-50 of 326) with videos related to
Sort By:
Page
of 33
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 9, 2021
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis
Jesús Rivera-Esteban, Angelo Armandi, Salvador Augustin, et al.
Metabolites
|
April 3, 2021
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism: Clinical and Experimental
|
November 21, 2024
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
BMJ (Clinical Research Ed.)
|
January 19, 2021
Management of non-alcoholic fatty liver disease
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology
|
October 27, 2025
Reply to Yang et al
Nuria Perez-Diaz-Del-Campo, Zobair M Younossi, Elisabetta Bugianesi
Metabolism: Clinical and Experimental
|
September 6, 2016
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists
Stergios A Polyzos, Elisabetta Bugianesi, Jannis Kountouras, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2013
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis
Federico Salomone, Giovanni Li Volti, Chiara Rosso, et al.
Nutrients
|
February 13, 2025
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies
Eleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, et al.
Frontiers in Endocrinology
|
December 3, 2021
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Nature Reviews. Gastroenterology & Hepatology
|
January 4, 2026
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Page
of 33